NCT06405802

Comparison of Technology-assisted and Face-to-face Assessment in Patients With Low Back Pain

Face-to-Face and Technology-Used Balance, Mobility and Strength Assessment in Patients With Low Back Pain
Izmir Katip Celebi University·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov
Study focus
Disease/Condition
Low Back Pain
Drug/Device/Intervention
Tele-evaluation
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Izmir Katip Celebi University
Location
İzmir, Turkey
Timeline & enrollment
Phase
N/A
Start date
Aug 10, 2022
End date
Mar 10, 2024
Enrollment
50 participants
Primary outcome

Oswestry disability index,Timed-up and go test,Single Leg Stance Test,Thirty Second Chair Stand Test

Summary

Although the concepts of telemedicine and tele-rehabilitation have been frequently emphasized
 in recent years, the evaluation part remains inadequate. There is no study investigating
 remote technology-based balance, mobility and strength assessments in patients with low back
 pain. Therefore, the aim of the study is; It is the examination of face-to-face and
 technology-based remote balance, mobility and strength assessment in patients with low back
 pain.

ICD-10 classifications
Low back painPain in thoracic spineContusion of lower back and pelvisInjuries to the abdomen, lower back, lumbar spine and pelvisSprain and strain of lumbar spine
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06405802
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06405802 through Pure Global AI's free database. This phase not specified trial is sponsored by Izmir Katip Celebi University and is currently Completed. The study focuses on Low Back Pain. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.